Strengthening Supply Chains for Veterinary and Pharmaceutical Products in Syria

June 06, 2025

Contents Overview

Syria has faced a number of issues that have affected its supply chains, including civil war, political instability, and sanctions. This has left the country grappling with shortages of essential goods, creating a dire humanitarian situation that has impacted millions creating obstacles for over a decade. A pivotal moment has arrived with the lifting of sanctions by governments, paving the way for potential reconstruction and the strengthening of supply chains.

As reported by the World Health Organization (WHO) on the state of Syria's healthcare system, only 57% of hospitals and 37% of health care centers are fully operational. Ongoing shortages of medicines and supplies continue to affect care. Strengthening pharmaceutical and veterinary supply chains is crucial to ensuring a path to recovery.

The recent lifting and easing of international sanctions by the U.S. government and the E.U. have brought renewed hope for the country and the wider region. This opens the door for a broader engagement and a more stable environment for essential health and veterinary services. Syrians now have the freedom to address critical shortages and begin reconstruction of vital healthcare infrastructure.

Discover over 4,000 medical products meeting the needs of 65+ international markets.

Impact of Sanctions on Syria’s Health System & Agricultural Sector

As reported by the Washington Post in January of this year, the impact of sanctions on the Syrian health system was dramatic. Although the international sanctions were not directly targeting health systems, they had indirectly and severely affected the country on multiple levels:

Because of equipment shortages and malfunctioning medical devices to a near collapse of the pharmaceutical supply chain most Syrians have relied on expensive and sometimes substandard pharmaceuticals. It should be noted that domestic pharmaceutical production once met 90% of the country's needs, an indication of a thriving industry.

Due to mass displacement, droughts, and the economic collapse, the rural population has halved, meaning that crop and livestock production have been damaged severely. It is estimated that the conflict in Syria has cost the agricultural sector 16 billion dollars, with over $3 billion in destroyed infrastructure alone.

Easing Sanctions: Impacts on Imports and Humanitarian Aid

With the lifting of sanctions in Syria, this could mean that the imports of vital products such as medicines to spare parts for machinery could become straightforward. Allowing supply chains to function more effectively, reducing delays, transaction costs and friction will help lift over 90% of Syrians out of poverty.

As sanctions on Syria begin to ease and are gradually lifted, operational constraints that once hindered trade and humanitarian aid are starting to loosen. Previously, aid organizations faced complex bureaucratic processes, unclear legal frameworks, and financial “de-risking” practices that delayed the flow of funds and supplies. Fuel shortages and logistical barriers further limited reach and effectiveness. With the reduction of these restrictions, humnatarian actors are now able to navigate supply chains more efficiently, enabling faster delivery of essential goods.

This improved environment is critical for rebuilding resilient and responsive supply chains, allowing aid efforts to focus on meeting urgent needs rather than managing compliance risks. As a result, programs in the health, water, sanitation, and shelter sectors can regain momentum, strengthening the overall humanitarian response in Syria.

With the removal of barriers this also paves the way for much-needed investment and infrastructure. Unblocking billions in stalled reconstruction work and direct foreign investment, enable operations to scale, including the pharmaceutical and agriculture sectors.

Access a comprehensive range of over 500 OTC and prescription treatments to enhance your portfolio and meet growing client and market demands.

Addressing Needs Through Quality and Affordability

AdvaCare Pharma recognizes the much needed supply of essential pharmaceuticals and veterinary medicines. With a mission to create a successful and lasting relationship with distributors based on trust, reliability, and transparency.

With a strong global presence in over 65 international markets, AdvaCare Pharma recognizes the importance of supplying essential pharmaceuticals such as antibiotics like Amoxicillin and pain relief medication such as Paracetamol

Especially with distribution partners in neighbouring countries such as Jordan, Iraq, and Turkey, placing AdvaCare Pharma in a strategic position to facilitate strengthening the supply of veterinary and pharmaceutical products into Syria, supporting the supply chain to recovery.

Delivering Quality Pharmaceutical Solutions & Partnerships

Our pharmaceutical portfolio includes essential medicines across 23 therapeutic classes in 13 dosage forms. With over 500 pharmaceutical treatments that are designed to tackle infections to pain relief.

With stringent quality monitoring and GMP-certified production, we guarantee high-quality and cost-effective, and reliable healthcare solutions.

AdvaCare Pharma has a mission to build long-lasting relationships with its regional distributing partners. As well as supplying the demand for much-needed pharmaceuticals and veterinary products. Our globally recognized and approved brands continually improve supply chains in the Middle East.

With over 250 veterinary products in our range, explore the potential to strengthen your portfolio and meet the growing needs of your clients.

Enhancing Veterinary Supply in Syria

Equally vital to the strengthening of supply chains to Syria is the availability of veterinary products for food and public health security. With the country's infrastructure heavily affected by sanctions, this has meant that veterinary products have not been able to reach veterinarians, resulting in lower yields and an increased disease burden.

AdvaCare Pharma veterinarian portfolio covers an extensive range of products, from antiparasitic medication to antibiotic Cefotaxime Injections. With over 250 treatments spanning over 18 therapeutic classes. Our veterinary portfolio covers animal health, preventing disease, and promoting livestock productivity.

We prioritize quality and affordability, enabling partners to satisfy demand while upholding standards for both patients and veterinarians. Our aim is not just to supply products - it is to support stronger, more reliable supply chains that improve long-term health outcomes. Our commitment is to provide distributors with high-quality products and comprehensive marketing support to facilitate product entry.

Our experience in the Middle East region has put AdvaCare Pharma in a good position to handle the successful streamlining of pharmaceutical and veterinary products.

AdvaCare Pharma prioritizes building long-lasting relationships. We foster a network of dependable distributors who share the goals of improving access to essential veterinary and pharmaceutical products to those who need them the most.

Fostering Dependable Distributors in Syria

Are you a qualified distributor looking to expand your pharmaceutical or veterinary portfolio in Syria? AdvaCare Pharma welcomes the opportunity to connect and explore how we can grow together through a trusted, long-term partnership.

WHO: 2025 “WHO calls for urgent support to rebuild Syria’s health system” TRES: 2025 “ Treasury Issues Immediate Sanctions Relief for Syria” Reuters: 2025 “EU agrees to lift economic sanctions on Syria, Kallas says” The Washington Post: 2025 "International sanctions have left Syria’s health system on life support” Carnegie Endowment for International Peace: 2024 “Syria’s Agricultural Crisis” PBS: 2025 "What lifting sanctions on Syria could mean for the war-torn country” HRW: 2023 “Questions and Answers: How Sanctions Affect the Humanitarian Response in Syria”